AmacaThera is developing a unique, injectable hydrogel platform technology for a wide range of medical applications. It’s first product aims to reduce the need for opioids and provide sustained relief for post-operative pain.
Trending at Lumira Ventures
Antiva Biosciences is a clinical-stage biopharmaceutical company developing novel, topical therapeutics for the treatment of diseases caused by HPV infection.
Arclight Therapeutics is building a portfolio of neurodegeneration companies to accelerate transformative neuroscience.
BioTheryX is a clinical-stage company with expertise in Targeted Protein Degradation with their novel, small molecule PHM to restore protein homeostasis and treat a wide range of diseases and serious cancers AML and MDS.
Bright Angel Therapeutics is a pre-clinical stage biotechnology company focused on the development of novel therapeutics for the treatment of drug-resistant and life-threatening fungal infections.
Cadence Neuroscience is developing a fundamentally new approach to neuromodulation with an unprecedented potential to treat many neurological diseases that cannot be adequately addressed with available treatment options.
Cardiac Dimensions is developing a minimally invasive implantable product to treat mitral valve regurgitation associated with congestive heart failure.
Congruence Therapeutics is a biotechnology company at the interface of computational and experimental drug discovery, designing novel small molecules to treat diseases caused by protein misfolding.
Corvia Medical is a private medical device company based in Massachusetts developing a catheter-delivered implant for treating diastolic heart failure.
Cyrano Therapeutics is a private, venture-backed clinical stage regenerative medicine company developing a novel therapy to restore smell and flavor function.
DAMONA is on a mission to develop small molecule therapeutics to improve the lives of patients suffering from cognitive impairment as a result of depression and other diseases of aging.
Deka Biosciences is developing novel cytokine therapies to drive cures in cancer patients and control inflammatory diseases
Edesa Biotech is a clinical stage pharmaceutical company that brings innovative new treatments for dermatological and anorectal diseases.
Endogenex is a clinical stage medical device company shifting the treatment paradigm for people living with Type 2 Diabetes by resetting the cellular signaling of the duodenum to help the body better manage blood sugar levels.
Endotronix, a digital health medtech company, is developing an integrated platform to provide comprehensive, reimbursable health management tools for patients suffering from advanced heart failure.